Nd a significant, time-dependent upregulation of inflammatory response-related genes with up
Nd a significant, time-dependent upregulation of inflammatory response-related genes with up to 4 h of LPS treatment (Figure 1). Because we found that most of the inflammatory response-related genes were upregulated at the 2- and 4-h time points, we chose of these time points for transcriptional profiling; these time points were also used in other studies [7,25,26] that investigated the XAV-939 site general induction pattern of microglial activation by LPS.Distinct gene signatures are identified during the inflammatory response according to RNA-Seq analysisPrimary microglial cells were cultured in the same condition as above. Primary microglial cells were treated with LPS (10 ng/ml), JQ1 (500 nM), and LPS (10 ng/ml) + JQ1 (500 nM) for 2 and 4 h. After treatment, the concentration of the pro-inflammatory mediators Ccl2, Ccl7, and Cxcl10 were determined in cell culture supernatants using the mouse enzyme-linked immunosorbent assay (ELISA) kit (Komabiotec, Seoul, Korea) according to the manufacturer’s protocol.Statistical analysisThe data were analyzed using Origin Pro 8 (Origin Lab Corporation, Northampton, MA, USA). Each value is expressed as the mean ?standard error of the mean (SEM). The statistical analysis was performed using SPSSTo identify the response of BV-2 cells to LPS (10 ng/mL), BV-2 cells were stimulated for two different time periods, that is, 2 and 4 h. RNA-Seq analysis revealed differentially expressed genes in the LPS-stimulated BV-2 cells at both time points: 270 genes for 2 h and 396 genes for 4 h (increased and decreased in PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28854080 expression fold change 1.5 log2 and P 0.01, respectively) were differentially regulated. Among them, 214 and 301 genes were upregulated, whereas 56 and 95 genes were downregulated at 2 and 4 h, respectively, after LPS treatment (Figure 2A,B and Additional file 2: Table S1 and S2). Notably, most of the upregulated genes included the following inflammatory response- and immune response-related genes: iNOS, interleukin and interleukin-related genes (Il1-, Il1a, Il18, Il1rn); Tnf- and Tnf–related genes (Tnfaip3, Tnip3, Tnip1, Tnfaip2); a prostaglandin-related gene, Ptgs2; NFB-related genes (Nfkbiz, Nfkbia, Nfkb2, Relb, Nfkbie, Nfkb1); interferon-related genes (Ifit1, interferon regulatory factors (Irf) Irf1, Irf7, Irf9); and cytokines or chemokines (Cxcl10, Ccl4, Ccl7, Ccl2, Ccl3, Ccl12, Ccl9) (Figure 2A,B,C,D). We selected these genes based on their biological processes and the molecular functions of their gene ontology. As the downregulated genes were not associated with inflammation, only upregulated genes were studied further. We confirmed by a GO analysis (FDR 0.05) using DAVID Bioinformatics Resources that LPS downregulated transcripts were associated with regulation of biological and cellular processes in BV-2 microglial cells (Figure 3C,D).Jung et al. Journal of Neuroinflammation (2015) 12:Page 6 ofFigure 1 Induction of inflammatory response-related genes in LPS-stimulated BV-2 microglial cells. Quantitative real-time reverse transcriptase PCR analysis of the expression of inflammatory genes in BV-2 microglial cells stimulated with LPS (10 ng/mL). Inflammatory genes were significantly upregulated in cells treated with LPS compared to untreated cells (*P < 0.05 and **P < 0.001) at the indicated times. Gene expression was normalized to GAPDH transcript levels. The data represent three independent experiments. The values are the mean ?SD of triplicate wells. LPS, lipopolysaccharide; GAPDH, glyceraldehyde-3ph.
